With a Bachelor's degree in Pharmacy and a Master's degree in Pharmacology, I have established a robust foundation in regulatory frameworks and essential medical concepts relevant to clinical practices.
Over the course of my career, I acquired significant expertise in clinical studies. As a medical writer for a Contract Research Organization (CRO) for two years, I actively contributed to the design and execution of Bioavailability/Bioequivalence (BA/BE) studies, as well as Phase I and Phase II trials. Following this, I transitioned to the role of a primary clinical reviewer at the Center for Drug Evaluation, where I spent two years critically assessing and reviewing new drug applications. In this capacity, I gained valuable insights into the regulatory landscape, specifically in evaluating clinical trial results encompassing efficacy and safety assessments, as well as conducting thorough risk and benefit evaluations.
Additionally, I played a pivotal role in the translation of technical documents, including Informed Consent Forms (ICF), Comprehensive Study Protocols (CSP), Clinical Study Reports (CSR), and various guidelines pertinent to clinical study projects. This multifaceted experience has equipped me with a comprehensive understanding of the intricacies of drug development, regulatory compliance, and effective communication within the pharmaceutical industry
Master Degree. 2015 - 2017
Bachelor's Degree. 2008 - 2013
With a Bachelor's degree in Pharmacy and a Master's degree in Pharmacology, I have established a robust foundation in regulatory frameworks and essential medical concepts relevant to clinical practices.
Over the course of my career, I acquired significant expertise in clinical studies. As a medical writer for a Contract Research Organization (CRO) for two years, I actively contributed to the design and execution of Bioavailability/Bioequivalence (BA/BE) studies, as well as Phase I and Phase II trials. Following this, I transitioned to the role of a primary clinical reviewer at the Center for Drug Evaluation, where I spent two years critically assessing and reviewing new drug applications. In this capacity, I gained valuable insights into the regulatory landscape, specifically in evaluating clinical trial results encompassing efficacy and safety assessments, as well as conducting thorough risk and benefit evaluations.
Additionally, I played a pivotal role in the translation of technical documents, including Informed Consent Forms (ICF), Comprehensive Study Protocols (CSP), Clinical Study Reports (CSR), and various guidelines pertinent to clinical study projects. This multifaceted experience has equipped me with a comprehensive understanding of the intricacies of drug development, regulatory compliance, and effective communication within the pharmaceutical industry
Master Degree. 2015 - 2017
Bachelor's Degree. 2008 - 2013